Functional reconstitution of a bacterial CO2 concentrating mechanism in E. coli

  1. Avi I Flamholz
  2. Eli Dugan
  3. Cecilia Blikstad
  4. Shmuel Gleizer
  5. Roee Ben-Nissan
  6. Shira Amram
  7. Niv Antonovsky
  8. Sumedha Ravishankar
  9. Elad Noor
  10. Arren Bar-Even
  11. Ron Milo  Is a corresponding author
  12. David Savage  Is a corresponding author
  1. University of California, Berkeley, United States
  2. Weizmann Institute of Science, Israel
  3. University of California, San Diego, United States
  4. ETH Zurich, Switzerland
  5. Max Planck Institute of Molecular Plant Physiology, Germany

Abstract

Many photosynthetic organisms employ a CO2 concentrating mechanism (CCM) to increase the rate of CO2 fixation via the Calvin cycle. CCMs catalyze ≈50% of global photosynthesis, yet it remains unclear which genes and proteins are required to produce this complex adaptation. We describe the construction of a functional CCM in a non-native host, achieved by expressing genes from an autotrophic bacterium in an E. coli strain engineered to depend on rubisco carboxylation for growth. Expression of 20 CCM genes enabled E. coli to grow by fixing CO2 from ambient air into biomass, with growth in ambient air depending on the components of the CCM. Bacterial CCMs are therefore genetically compact and readily transplanted, rationalizing their presence in diverse bacteria. Reconstitution enabled genetic experiments refining our understanding of the CCM, thereby laying the groundwork for deeper study and engineering of the cell biology supporting CO2 assimilation in diverse organisms.

Data availability

All source data for all figures is available in the linked github repository along with accompanying Jupyter notebooks generating the data-driven portions of all figures.

Article and author information

Author details

  1. Avi I Flamholz

    Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9278-5479
  2. Eli Dugan

    Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2400-5511
  3. Cecilia Blikstad

    Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5740-926X
  4. Shmuel Gleizer

    Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    No competing interests declared.
  5. Roee Ben-Nissan

    Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    No competing interests declared.
  6. Shira Amram

    Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    No competing interests declared.
  7. Niv Antonovsky

    Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    No competing interests declared.
  8. Sumedha Ravishankar

    Division of Biological Sciences, University of California, San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4026-0742
  9. Elad Noor

    Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8776-4799
  10. Arren Bar-Even

    Max Planck Institute of Molecular Plant Physiology, Potsdam, Germany
    Competing interests
    Arren Bar-Even, A.B.-E. is co-founder of b.fab, a company aiming to commercialize engineered C1-assimilation in microorganisms. The company was not involved in this work in any way..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1039-4328
  11. Ron Milo

    Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
    For correspondence
    ron.milo@weizmann.ac.il
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1641-2299
  12. David Savage

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
    For correspondence
    savage@berkeley.edu
    Competing interests
    David Savage, D.F.S. is a co-founder of Scribe Therapeutics and a scientific advisory board member of Scribe Therapeutics and Mammoth Biosciences. These companies were not involved in this work in any way..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0042-2257

Funding

Energy Biosciences Institute (CW163755)

  • David Savage

US Department of Energy (DE-SC00016240)

  • David Savage

European Research Council (NOVCARBFIX 646827)

  • Ron Milo

National Science Foundation (MCB-1818377)

  • David Savage

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Manajit Hayer-Hartl, Max Planck Institute of Biochemistry, Germany

Publication history

  1. Received: June 11, 2020
  2. Accepted: October 20, 2020
  3. Accepted Manuscript published: October 21, 2020 (version 1)
  4. Version of Record published: December 3, 2020 (version 2)

Copyright

© 2020, Flamholz et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,207
    Page views
  • 1,178
    Downloads
  • 41
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Avi I Flamholz
  2. Eli Dugan
  3. Cecilia Blikstad
  4. Shmuel Gleizer
  5. Roee Ben-Nissan
  6. Shira Amram
  7. Niv Antonovsky
  8. Sumedha Ravishankar
  9. Elad Noor
  10. Arren Bar-Even
  11. Ron Milo
  12. David Savage
(2020)
Functional reconstitution of a bacterial CO2 concentrating mechanism in E. coli
eLife 9:e59882.
https://doi.org/10.7554/eLife.59882

Further reading

    1. Biochemistry and Chemical Biology
    2. Developmental Biology
    Zengdi Zhang, Zan Huang ... Hai-Bin Ruan
    Research Article Updated

    In mammals, interactions between the bone marrow (BM) stroma and hematopoietic progenitors contribute to bone-BM homeostasis. Perinatal bone growth and ossification provide a microenvironment for the transition to definitive hematopoiesis; however, mechanisms and interactions orchestrating the development of skeletal and hematopoietic systems remain largely unknown. Here, we establish intracellular O-linked β-N-acetylglucosamine (O-GlcNAc) modification as a posttranslational switch that dictates the differentiation fate and niche function of early BM stromal cells (BMSCs). By modifying and activating RUNX2, O-GlcNAcylation promotes osteogenic differentiation of BMSCs and stromal IL-7 expression to support lymphopoiesis. In contrast, C/EBPβ-dependent marrow adipogenesis and expression of myelopoietic stem cell factor (SCF) is inhibited by O-GlcNAcylation. Ablating O-GlcNAc transferase (OGT) in BMSCs leads to impaired bone formation, increased marrow adiposity, as well as defective B-cell lymphopoiesis and myeloid overproduction in mice. Thus, the balance of osteogenic and adipogenic differentiation of BMSCs is determined by reciprocal O-GlcNAc regulation of transcription factors, which simultaneously shapes the hematopoietic niche.

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Hilary Scott, Boris Novikov ... Vladislav Panin
    Research Article

    Modification by sialylated glycans can affect protein functions, underlying mechanisms that control animal development and physiology. Sialylation relies on a dedicated pathway involving evolutionarily conserved enzymes, including CMP-sialic acid synthetase (CSAS) and sialyltransferase (SiaT) that mediate the activation of sialic acid and its transfer onto glycan termini, respectively. In Drosophila, CSAS and DSiaT genes function in the nervous system, affecting neural transmission and excitability. We found that these genes function in different cells: the function of CSAS is restricted to glia, while DSiaT functions in neurons. This partition of the sialylation pathway allows for regulation of neural functions via a glia-mediated control of neural sialylation. The sialylation genes were shown to be required for tolerance to heat and oxidative stress and for maintenance of the normal level of voltage-gated sodium channels. Our results uncovered a unique bipartite sialylation pathway that mediates glia-neuron coupling and regulates neural excitability and stress tolerance.